Orel Everett
Family Medicine · Corpus Christi, TXNPI 1164509659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 372 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,495 and has fallen 65.8% since, to $853 in 2021.
Across 372 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$796
- Amarin Pharma, Inc.$456
- Lilly USA, LLC$401
- Pfizer$391
- Johnson & Johnson$368
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,15698%
- Education$1072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 113 | $1,143 |
| AstraZeneca | 27 | $796 |
| Amarin Pharma, Inc. | 16 | $456 |
| Lilly USA, LLC | 33 | $401 |
| Pfizer | 40 | $391 |
| Johnson & Johnson | 14 | $368 |
| Arbor Pharmaceuticals, Inc. | 40 | $317 |
| Novartis | 17 | $263 |
| AbbVie(2 entities) | 17 | $218 |
| Abbott | 4 | $160 |
| GSK | 9 | $155 |
| Merck | 12 | $142 |
| Boehringer Ingelheim | 9 | $120 |
| Esperion Therapeutics, Inc. | 4 | $74 |
| Amgen | 4 | $71 |
| Kowa Pharmaceuticals America, Inc. | 5 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Radius Health, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$164
- XARELTO$125
- Proclaim Family of SCS IPGs$124
- Vascepa$116
- BYDUREON$101
How this compares
$5,263 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 25 | $863 |
| Atorvastatin Calcium | 17 | $269 |
| Metoprolol Tartrate | 25 | $244 |
| Losartan Potassium | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Corpus Christi
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.